Simeprevir and Sofosbuvir with Ribavirin in previously treated HIV positive patients with hepatitis C and cirrhosis.

Trial Profile

Simeprevir and Sofosbuvir with Ribavirin in previously treated HIV positive patients with hepatitis C and cirrhosis.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 26 Apr 2015

At a glance

  • Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
  • Indications Hepatitis C; Liver cirrhosis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms STOP-C
  • Most Recent Events

    • 09 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top